TNF and COVID-19: Some researchers have even speculated that methotrexate may inhibit the expression of TNF-α, IL-6 and other pro-inflammatory cytokines released with SARS-CoV-2, thereby reducing the cytokine storm associated with COVID-19 (44, 45).